Acute tubular necrosis causes: Difference between revisions
No edit summary |
|||
Line 28: | Line 28: | ||
* Toxic acute tubular necrosis: | * Toxic acute tubular necrosis: | ||
** Exogenous nephrotoxins: | ** Exogenous nephrotoxins: | ||
*** Aminoglycosides | *** Aminoglycosides<ref name="pmid10223907">{{cite journal |vauthors=Mingeot-Leclercq MP, Tulkens PM |title=Aminoglycosides: nephrotoxicity |journal=Antimicrob. Agents Chemother. |volume=43 |issue=5 |pages=1003–12 |date=May 1999 |pmid=10223907 |pmc=89104 |doi= |url=}}</ref> | ||
*** Amphotericin B | *** Amphotericin B<ref name="pmid11154026">{{cite journal |vauthors=Fanos V, Cataldi L |title=Amphotericin B-induced nephrotoxicity: a review |journal=J Chemother |volume=12 |issue=6 |pages=463–70 |date=December 2000 |pmid=11154026 |doi=10.1179/joc.2000.12.6.463 |url=}}</ref> | ||
*** Contrast media | *** Contrast media<ref name="pmid7455084">{{cite journal |vauthors=Lang EK, Foreman J, Schlegel JU, Leslie C, List A, McCormick P |title=The incidence of contrast medium induced acute tubular necrosis following arteriography |journal=Radiology |volume=138 |issue=1 |pages=203–6 |date=January 1981 |pmid=7455084 |doi=10.1148/radiology.138.1.7455084 |url=}}</ref> | ||
*** Cisplatin | *** Cisplatin<ref name="pmid9315405">{{cite journal |vauthors=Wadd NJ, Tiplady C, Roberts JT |title=Cisplatin and acute tubular necrosis |journal=Clin Oncol (R Coll Radiol) |volume=9 |issue=4 |pages=267–8 |date=1997 |pmid=9315405 |doi= |url=}}</ref> | ||
*** Ifosfamide | *** Ifosfamide<ref name="pmid8625132">{{cite journal |vauthors=Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE |title=Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients |journal=Cancer |volume=76 |issue=3 |pages=497–500 |date=August 1995 |pmid=8625132 |doi= |url=}}</ref> | ||
*** Foscarnet | *** Foscarnet<ref name="pmid2554731">{{cite journal |vauthors=Deray G, Martinez F, Katlama C, Levaltier B, Beaufils H, Danis M, Rozenheim M, Baumelou A, Dohin E, Gentilini M |title=Foscarnet nephrotoxicity: mechanism, incidence and prevention |journal=Am. J. Nephrol. |volume=9 |issue=4 |pages=316–21 |date=1989 |pmid=2554731 |doi=10.1159/000167987 |url=}}</ref> | ||
*** Pentamidine | *** Pentamidine<ref name="pmid23401840">{{cite journal |vauthors=Prabhavalkar S, Masengu A, O'Rourke D, Shields J, Courtney A |title=Nebulized pentamidine-induced acute renal allograft dysfunction |journal=Case Rep Transplant |volume=2013 |issue= |pages=907593 |date=2013 |pmid=23401840 |pmc=3562641 |doi=10.1155/2013/907593 |url=}}</ref> | ||
*** Cidofovir | *** Cidofovir<ref name="pmid15751777">{{cite journal |vauthors=Ortiz A, Justo P, Sanz A, Melero R, Caramelo C, Guerrero MF, Strutz F, Müller G, Barat A, Egido J |title=Tubular cell apoptosis and cidofovir-induced acute renal failure |journal=Antivir. Ther. (Lond.) |volume=10 |issue=1 |pages=185–90 |date=2005 |pmid=15751777 |doi= |url=}}</ref> | ||
*** Tenofovir | *** Tenofovir <ref name="pmid20811330">{{cite journal |vauthors=Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS |title=Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities |journal=Kidney Int. |volume=78 |issue=11 |pages=1171–7 |date=December 2010 |pmid=20811330 |doi=10.1038/ki.2010.318 |url=}}</ref> | ||
*** Bisphosphonates | *** Bisphosphonates<ref name="pmid18685574">{{cite journal |vauthors=Perazella MA, Markowitz GS |title=Bisphosphonate nephrotoxicity |journal=Kidney Int. |volume=74 |issue=11 |pages=1385–93 |date=December 2008 |pmid=18685574 |doi=10.1038/ki.2008.356 |url=}}</ref> | ||
*** Cephalosporin | *** Cephalosporin<ref name="pmid15222673">{{cite journal |vauthors=Longstreth KL, Robbins SD, Smavatkul C, Doe NS |title=Cephalexin-induced acute tubular necrosis |journal=Pharmacotherapy |volume=24 |issue=6 |pages=808–11 |date=June 2004 |pmid=15222673 |doi=10.1592/phco.24.8.808.36069 |url=}}</ref> | ||
*** Naproxen | *** Naproxen<ref name="pmid12774222">{{cite journal |vauthors=Kovacevic L, Bernstein J, Valentini RP, Imam A, Gupta N, Mattoo TK |title=Renal papillary necrosis induced by naproxen |journal=Pediatr. Nephrol. |volume=18 |issue=8 |pages=826–9 |date=August 2003 |pmid=12774222 |doi=10.1007/s00467-003-1167-4 |url=}}</ref> | ||
*** Tacrolimus | *** Tacrolimus<ref name="pmid19338495">{{cite journal |vauthors=Ardalan MR, Nasri H, Ghabili K, Mohajel Shoja M |title=Acute tubular necrosis after renal allograft segmental infarction: the nephrotoxicity of necrotic material |journal=Exp Clin Transplant |volume=6 |issue=4 |pages=312–4 |date=December 2008 |pmid=19338495 |doi= |url=}}</ref> | ||
*** Mannitol | *** Mannitol<ref name="pmid2111870">{{cite journal |vauthors=Dorman HR, Sondheimer JH, Cadnapaphornchai P |title=Mannitol-induced acute renal failure |journal=Medicine (Baltimore) |volume=69 |issue=3 |pages=153–9 |date=May 1990 |pmid=2111870 |doi= |url=}}</ref> | ||
*** Intravenous immunoglobulins: These contain sucrose which is toxic to tubular cells. | *** Intravenous immunoglobulins:<ref name="pmid17768831">{{cite journal |vauthors=Fakhouri F |title=[Intravenous immunoglobulins and acute renal failure: mechanism and prevention] |language=French |journal=Rev Med Interne |volume=28 Spec No. 1 |issue= |pages=4–6 |date=May 2007 |pmid=17768831 |doi= |url=}}</ref> These contain sucrose which is toxic to tubular cells. | ||
*[Cause1] | *[Cause1] |
Revision as of 19:01, 3 May 2018
Acute tubular necrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute tubular necrosis causes On the Web |
American Roentgen Ray Society Images of Acute tubular necrosis causes |
Risk calculators and risk factors for Acute tubular necrosis causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]
Overview
Disease name] may be caused by [cause1], [cause2], or [cause3].
OR
Common causes of [disease] include [cause1], [cause2], and [cause3].
OR
The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].
OR
The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.
Causes
Life-threatening Causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of disease name, however complications resulting from untreated disease name is common.
- Life-threatening causes of [symptom/manifestation] include [cause1], [cause2], and [cause3].
- [Cause] is a life-threatening cause of [disease].
Common Causes
[Disease name] may be caused by:
- Toxic acute tubular necrosis:
- Exogenous nephrotoxins:
- Aminoglycosides[1]
- Amphotericin B[2]
- Contrast media[3]
- Cisplatin[4]
- Ifosfamide[5]
- Foscarnet[6]
- Pentamidine[7]
- Cidofovir[8]
- Tenofovir [9]
- Bisphosphonates[10]
- Cephalosporin[11]
- Naproxen[12]
- Tacrolimus[13]
- Mannitol[14]
- Intravenous immunoglobulins:[15] These contain sucrose which is toxic to tubular cells.
- Exogenous nephrotoxins:
- [Cause1]
- [Cause2]
- [Cause3]
OR
- [Disease name] is caused by an infection with [pathogen name].
- [Pathogen name] is caused by [pathogen name].
Less Common Causes
Less common causes of disease name include:
- [Cause1]
- [Cause2]
- [Cause3]
Genetic Causes
- [Disease name] is caused by a mutation in the [gene name] gene.
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | No underlying causes |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List the causes of the disease in alphabetical order.
References
- ↑ Mingeot-Leclercq MP, Tulkens PM (May 1999). "Aminoglycosides: nephrotoxicity". Antimicrob. Agents Chemother. 43 (5): 1003–12. PMC 89104. PMID 10223907.
- ↑ Fanos V, Cataldi L (December 2000). "Amphotericin B-induced nephrotoxicity: a review". J Chemother. 12 (6): 463–70. doi:10.1179/joc.2000.12.6.463. PMID 11154026.
- ↑ Lang EK, Foreman J, Schlegel JU, Leslie C, List A, McCormick P (January 1981). "The incidence of contrast medium induced acute tubular necrosis following arteriography". Radiology. 138 (1): 203–6. doi:10.1148/radiology.138.1.7455084. PMID 7455084.
- ↑ Wadd NJ, Tiplady C, Roberts JT (1997). "Cisplatin and acute tubular necrosis". Clin Oncol (R Coll Radiol). 9 (4): 267–8. PMID 9315405.
- ↑ Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE (August 1995). "Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients". Cancer. 76 (3): 497–500. PMID 8625132.
- ↑ Deray G, Martinez F, Katlama C, Levaltier B, Beaufils H, Danis M, Rozenheim M, Baumelou A, Dohin E, Gentilini M (1989). "Foscarnet nephrotoxicity: mechanism, incidence and prevention". Am. J. Nephrol. 9 (4): 316–21. doi:10.1159/000167987. PMID 2554731.
- ↑ Prabhavalkar S, Masengu A, O'Rourke D, Shields J, Courtney A (2013). "Nebulized pentamidine-induced acute renal allograft dysfunction". Case Rep Transplant. 2013: 907593. doi:10.1155/2013/907593. PMC 3562641. PMID 23401840.
- ↑ Ortiz A, Justo P, Sanz A, Melero R, Caramelo C, Guerrero MF, Strutz F, Müller G, Barat A, Egido J (2005). "Tubular cell apoptosis and cidofovir-induced acute renal failure". Antivir. Ther. (Lond.). 10 (1): 185–90. PMID 15751777.
- ↑ Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS (December 2010). "Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities". Kidney Int. 78 (11): 1171–7. doi:10.1038/ki.2010.318. PMID 20811330.
- ↑ Perazella MA, Markowitz GS (December 2008). "Bisphosphonate nephrotoxicity". Kidney Int. 74 (11): 1385–93. doi:10.1038/ki.2008.356. PMID 18685574.
- ↑ Longstreth KL, Robbins SD, Smavatkul C, Doe NS (June 2004). "Cephalexin-induced acute tubular necrosis". Pharmacotherapy. 24 (6): 808–11. doi:10.1592/phco.24.8.808.36069. PMID 15222673.
- ↑ Kovacevic L, Bernstein J, Valentini RP, Imam A, Gupta N, Mattoo TK (August 2003). "Renal papillary necrosis induced by naproxen". Pediatr. Nephrol. 18 (8): 826–9. doi:10.1007/s00467-003-1167-4. PMID 12774222.
- ↑ Ardalan MR, Nasri H, Ghabili K, Mohajel Shoja M (December 2008). "Acute tubular necrosis after renal allograft segmental infarction: the nephrotoxicity of necrotic material". Exp Clin Transplant. 6 (4): 312–4. PMID 19338495.
- ↑ Dorman HR, Sondheimer JH, Cadnapaphornchai P (May 1990). "Mannitol-induced acute renal failure". Medicine (Baltimore). 69 (3): 153–9. PMID 2111870.
- ↑ Fakhouri F (May 2007). "[Intravenous immunoglobulins and acute renal failure: mechanism and prevention]". Rev Med Interne (in French). 28 Spec No. 1: 4–6. PMID 17768831.